Exhibit 99.7 Avocent Reports First Quarter Results HUNTSVILLE, Ala.--(BUSINESS WIRE)--April 18, 2007--Avocent Corporation (NASDAQ:AVCT) today reported financial results for the first quarter ended March 30, 2007. Net sales for the first quarter increased 41.7% to $134 million, consistent with the expected range provided on April 9, 2007, compared with $94.5 million reported for the first quarter of 2006. "As we detailed on April 9, 2007, Avocent's first quarter sales were below our expectations due to softness in IT spending, project delays by some customers and a lower level of economic activity than we had forecast," stated John R. Cooper, chairman and chief executive officer of Avocent Corporation. "As a result, our growth in sales from the first quarter of 2006 was due primarily to the contributions from our acquisitions of Cyclades and LANDesk last year." "Our product suites are very competitive, and we remain positive about the outlook for Avocent. The addition of Cyclades extended our markets for serial-based management products and the LANDesk acquisition adds a new market for Avocent with a suite of IT management software products and strength in desktop management. We expect to leverage our combined products lines to expand future growth opportunities," continued Mr. Cooper. First Quarter Results First quarter 2007 operational income, which is income prior to intangible amortization, stock compensation and acquired in-process research and development expenses, was $12.7 million, or $0.25 per diluted share, compared with $17.4 million, or $0.35 per diluted share, in the first quarter of 2006. (See "Use of Non-GAAP Financial Measures" discussion below.) GAAP net income for the first quarter of 2007 was $746,000, or $0.01 per diluted share. This compares with GAAP net income of $12.9 million, or $0.26 per diluted share, in the first quarter of 2006. Net adjustments to reconcile operational income to GAAP net income were $12.0 million in the first quarter of 2007, including $11.6 million in intangible amortization, $3.7 million in stock compensation expenses and $4.1 million in related income tax benefits. Net adjustments to reconcile to GAAP net income were $4.5 million in the first quarter of 2006, including $2.4 million in intangible amortization, $2.1 million in acquired in-process research and development, $0.8 million in stock compensation expenses and $1.0 million in related income tax benefits. Branded sales increased 79% from the first quarter of 2006 and accounted for 64.1% of total first quarter 2007 sales. Growth in branded sales was due largely to the acquisitions of Cyclades and LANDesk. OEM sales increased 3.3% from the first quarter of 2006 and accounted for 35.9% of total first quarter 2007 sales. U.S. sales increased 42% to $74.2 million and international sales rose 42% to $59.7 million compared with the first quarter of 2006. Gross profit for the first quarter of 2007 increased 51.2% to $84.7 million with a gross margin of 63.2%. This compared with gross profit of $56.0 million and a gross margin of 59.3% in the first quarter of 2006. The increase in gross margin was due to higher sales and improved product mix, including increased sales of digital products and the addition of LANDesk's software revenues. Research and development expenses increased 53.1% to $19.8 million ($20.9 million on a GAAP basis, which includes stock-based compensation of $1.1 million), or 14.8% of sales, compared with $12.9 million, or 13.7% of sales, in the first quarter of 2006. "Our R&D spending increased from last year due primarily from the addition of LANDesk and Cyclades teams," continued Mr. Cooper. "Our focus remains on integrating the Avocent and LANDesk software platforms and bringing new technologies to market while improving the performance and cost of existing products and services." Selling, general and administrative expenses increased to $46.3 million ($48.7 million on a GAAP basis, which includes stock-based compensation of $2.4 million) compared with $22.7 million in the first quarter of 2006. The increase in SG&A expenses was due primarily to the addition of Cyclades and LANDesk and additional marketing expenditures for recently introduced products. Total employee count increased to approximately 1,800 primarily as a result of the Cyclades and LANDesk acquisitions. Avocent's cash flow from operations was approximately $18.8 million for the first quarter of 2007. At the end of the first quarter, Avocent's cash, cash equivalents and investments totaled approximately $109 million. Avocent repurchased approximately 486,000 shares during the first quarter at a total cost of approximately $15.4 million. First Quarter Division Results Revenues from the Management Systems Division advanced to $105.1 million in the first quarter of 2007 from $90.5 million in the first quarter of 2006, primarily as a result of the Cyclades acquisition, while operating income from this division increased to $25.9 million in the first quarter of 2007. The LANDesk Division produced revenues of $23.9 million in the first quarter of 2007 with an operating loss of $0.5 million. LANDesk was acquired by Avocent effective August 31, 2006. Revenues from the two emerging businesses increased to $4.2 million in the first quarter of 2007 from $3.0 million in the first quarter of 2006, while operating losses from these divisions increased to $3.1 million in the first quarter of 2007 from $2.7 million in the first quarter of 2006. Use of Non-GAAP Financial Measures Income prior to intangible amortization, stock compensation and acquired in-process research and development expenses, or operational income as used in the attached financial statement schedules, is not a measure of financial performance under generally accepted accounting principles (GAAP) and should not be considered a substitute for or superior to GAAP. Avocent's management uses operational income as a financial measure to evaluate performance and allocate resources within the Company. Management believes this measure presents the Company's results on a more comparable operational basis by excluding non-cash amortization expenses, non-operational expenses associated with acquisitions, and non-cash stock-based compensation expense. Avocent believes that operational income is a measure of performance used by some investment banks, analysts, investors and others to make informed investment decisions. Other companies may calculate operational income in a different manner so this measure may not be comparable to similar measures presented by other companies. A reconciliation of Avocent's results using operational measures and GAAP is set forth in the condensed consolidated statements of operations included in this press release. Conference Call and Additional Information Avocent will provide an on-line, real-time webcast and rebroadcast of its first quarter results conference call to be held April 19, 2007. The live broadcast will be available on-line at www.avocent.com as well as www.investorcalendar.com beginning at 10:00 a.m. Central time. The on-line replay will follow immediately and continue for 30 days. Avocent has also furnished additional commentary on the first quarter results simultaneously with this release on a Form 8-K filed with the SEC and on its website. About Avocent Corporation Avocent delivers IT operations and infrastructure management solutions for enterprises worldwide, helping customers to reduce costs and simplify complex IT environments via integrated, centralized in-band and out-of-band hardware and software. Through LANDesk, Avocent also is a leading provider of systems, security, and process management solutions. Additional information is available at: www.avocent.com. Forward-Looking Statements This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the outlook for future sales, the expanded markets and growth opportunities resulting from the integration of Cyclades serial-based management products and LANDesk's management suite into Avocent products, and our continued focus on integrating software platforms and bringing new technologies to market while improving the performance and cost of our existing products and services. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, including the risks associated with general economic conditions, risks attributable to future product demand, sales, and expenses, risks associated with reliance on a limited number of customers, component suppliers, and single source components, risks associated with acquisitions and acquisition integration, risks associated with product design efforts and the introduction of new products and technologies, and risks associated with obtaining and protecting intellectual property rights. Other factors that could cause operating and financial results to differ are described in our annual report on Form 10-K filed with the Securities and Exchange Commission on March 1, 2007. Other risks may be detailed from time to time in reports to be filed with the SEC. Avocent does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof. AVOCENT CORPORATION Condensed Consolidated Statements of Income (Unaudited, in thousands, except per share data) For the Quarter Ended March 30, 2007 Stock Operational Compensation(1) Adjustments(2) GAAP ----------- ---------------- -------------- --------- Net sales $133,932 $(781) $133,151 Cost of sales 49,274 $179 2,683 52,136 ----------- ---------------- -------------- --------- Gross profit 84,658 (179) (3,464) 81,015 Research and development expenses 19,765 $1,116 20,881 Selling, general and administrative expenses 46,282 2,366 12 48,660 Amortization of intangible assets - - 8,962 8,962 ----------- ---------------- -------------- --------- Operating income 18,611 (3,661) (12,438) 2,512 Other income (expense), net (1,672) - - (1,672) ----------- ---------------- -------------- --------- Income before provision for income taxes 16,939 (3,661) (12,438) 840 Provision for income taxes 4,226 (1,005) (3,127) 94 ----------- ---------------- -------------- --------- Net income $12,713 $(2,656) $(9,311) $746 =========== ================ ============== ========= Earnings per share: Basic $0.25 $0.01 Diluted $0.25 $0.01 Weighted average shares and common equivalents outstanding: Basic 50,733 - - 50,733 Diluted 51,886 - - 51,886 For the Quarter Ended March 31, 2006 Stock Operational Compensation(1) Adjustments(2) GAAP ----------- ---------------- -------------- --------- Net sales $94,512 $94,512 Cost of sales 38,505 $50 38,555 ----------- ---------------- -------------- --------- Gross profit 56,007 (50) 55,957 Research and development expenses 12,908 $301 13,209 Acquired in- process research and development expenses - - $2,100 2,100 Selling, general and administrative expenses 22,743 490 151 23,384 Amortization of intangible assets - 2,351 2,351 ----------- ---------------- -------------- --------- Operating income 20,356 (841) (4,602) 14,913 Other income (expense), net 3,016 - - 3,016 ----------- ---------------- -------------- --------- Income before provision for income taxes 23,372 (841) (4,602) 17,929 Provision for income taxes 5,952 (262) (694) 4,996 ----------- ---------------- -------------- --------- Net income $17,420 $(579) $(3,908) $12,933 =========== ================ ============== ========= Earnings per share: Basic $0.35 $0.26 Diluted $0.35 $0.26 Weighted average shares and common equivalents outstanding: Basic 49,095 - - 49,095 Diluted 50,109 - - 50,109 (1) Stock Compensation relates to expensing of stock options, restricted stock units, and performance shares. Avocent adopted SFAS 123R effective January 1, 2006 and began recording expense related to outstanding unvested stock options on that date as well as on subsequent equity compensation grants. (2) Adjustments related to acquired in-process research and development expense from the Cyclades acquisition, depreciation and amortization of the purchase accounting adjustment to deferred revenue and intangibles recorded as the result of acquisitions. AVOCENT CORPORATION Condensed Consolidated Balance Sheets (Unaudited, in thousands) March 30, December 31, 2007 2006 ------------- ------------- Cash, cash equivalents and short-term investments $108,939 $107,165 Accounts receivable, net 109,192 126,471 Inventories, net 40,137 41,765 Other current assets 17,900 17,269 Deferred income tax 8,705 7,355 ------------- ------------- Total current assets 284,873 300,025 Investments - 987 Property and equipment, net 38,087 38,004 Goodwill 606,787 607,488 Intangible assets, net 199,235 209,674 Other assets 2,370 2,676 ------------- ------------- Total assets $1,131,352 $1,158,854 ============= ============= Accounts payable and other accrued expenses $31,381 $41,771 Income tax payable 20,340 17,364 Deferred revenue 45,144 44,453 Other current liabilities 24,756 29,754 ------------- ------------- Total current liabilities 121,621 133,342 Line of credit obligation 150,000 150,000 Deferred income taxes 28,137 30,377 Deferred revenue, net of current portion 9,593 10,070 Other non-current liabilities 872 1,222 ------------- ------------- Total liabilities 310,223 325,011 Total stockholders' equity 821,129 833,843 ------------- ------------- Total liabilities and stockholders' equity $1,131,352 $1,158,854 ============= ============= AVOCENT CORPORATION Additional Financial Information (Unaudited, in thousands) Quarter Ended ------------------------------------ March 30, March 31, March 31, 2007 2006 2006 As if Actual Combined ----------- ----------- ------------ Revenue by Distribution Channel - ---------------------------------- Branded $85,825 $47,955 $81,643 OEM 48,107 46,557 49,265 ----------- ----------- ------------ Total $133,932 $94,512 $130,908 =========== =========== ============ Revenue by Division - ---------------------------------- Management Systems $105,104 $90,498 $104,453 LANDesk 23,854 - 22,441 Other business units 4,224 3,021 3,021 Corporate and unallocated 750 993 993 ----------- ----------- ------------ Total $133,932 $94,512 $130,908 =========== =========== ============ Management Systems Division Revenue by Product Line - ---------------------------------- KVM $80,688 $77,975 $78,680 Serial Management 11,286 993 11,921 Embedded Software and Solutions 7,577 6,133 6,133 Other 5,553 5,397 7,719 ----------- ----------- ------------ Total $105,104 $90,498 $104,453 =========== =========== ============ LANDesk Division Revenues by Type - ---------------------------------- Licenses and royalties $13,371 $- $13,748 Maintenance and services 10,483 - 8,693 ----------- ----------- ------------ Total $23,854 $- $22,441 =========== =========== ============ Operating Profit (Loss) by Division - ---------------------------------- Management Systems $25,911 $25,783 LANDesk (536) - Other business units (3,149) (2,698) Corporate and unallocated (3,615) (2,729) ----------- ----------- Total $18,611 $20,356 =========== =========== Cash Flow Highlights - ---------------------------------- Cash provided by operations $18,804 $16,564 Depreciation expense 2,354 1,774 Capital expenditures 2,651 1,689 Purchase of treasury shares 15,437 26,952 CONTACT: Avocent Corporation Edward H. Blankenship Senior Vice President of Finance and Chief Financial Officer 256-217-1301